Now showing items 1-2 of 2
Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine
(Springer-Verlag, 1994-01)
We searched for methods that would enable prescriptions of the maximum tolerable doses of iodine-131 metaiodobenzylguanidine (MIBG) and iodine-125 MIBG in the treatment of patients with neuroblastoma. We correlated doses, ...
Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine
(Springer-Verlag, 1991-03)
Phaeochromocytomas and functioning paragangliomas are rare tumours in childhood and adolescence. We review our experience of 43 cases (24 men, 19 women) who were first diagnosed at the age of ⩽ 18 years. All patients were ...